Objective: To examine racial/ethnic differences in Medicare beneficiary experiences with Medicare Part D prescription drug (PD) coverage.
R esearch consistently demonstrates that racial/ethnic minorities experience disparities in patient experience at multiple levels of care, including insurance plans, hospitals, and individual providers. Minority and low socioeconomic status (SES) patients of all ages also have poorer health outcomes for a wide variety of conditions than their non-Hispanic White or higher SES counterparts. 1 In particular, racial/ethnic disparities in both clinical process measures and patient experiences of care are well documented in the Medicare population. [2] [3] [4] In some cases these racial/ethnic health disparities can be linked to differential access or selection into plans or providers of differing quality. For instance, Black race and Hispanic ethnicity, lower income and educational attainment, poor health status and older age have been associated with problems related to health care insurance and access. 5, 6 Goldstein et al 7 reported that non-Hispanic Whites receive care from hospitals that provide better experiences on average for all patients than the hospitals more often used by nonWhite patients. Weech-Maldonado et al 8 similarly found that Blacks, Hispanic-Spanish speakers, and Native Americans are more likely to be concentrated in Medicaid-managed care plans than the White English speakers, which provide worse patient experiences on average for all beneficiaries than those in which non-Hispanic White patients were more often enrolled.
Other possible explanations for racial/ethnic health disparities might apply to patients within the same plans, hospitals, or individual providers, and might include language and communication issues for patients for whom English is not their primary language or who have limited health literacy. 9, 10 Another possibility for racial/ethnic disparities might be differential treatment by providers and plans on the basis of the patient characteristics.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 created prescription drug (PD) coverage for Medicare beneficiaries through a new Part D program, the largest single addition to Medicare since its creation in 1965. This legislation restructured PD coverage for all Medicare beneficiaries and granted coverage to many previously uncovered beneficiaries. Starting in 2006, Medicare beneficiaries could select PD coverage through a standalone prescription drug plan (PDP) if they were enrolled in traditional fee-for-service (FFS) Medicare or as an integrated option for beneficiaries in a Medicare Advantage (MA) contract (MA-PD).
In 2008, 19% of beneficiaries were enrolled in MA, 11 which increased to 25% by 2011. 12 Most MA contracts offer PD coverage and 87%/90% of MA beneficiaries in 2008/ 2011 were enrolled in an MA-PD contract. 13 FFS beneficiaries and enrollees of the few MA contracts that do not offer PD coverage (such as private-fee-for-services contracts) are eligible to enroll in stand-alone PDPs. In 2008 and 2011, about half of FFS beneficiaries were enrolled in a PDP. 13 Many of these PDP contracts are geographically extensive, with enrollment sometimes spanning many states. Part D contracts, either MA-PD or PDP, consist of Z1 benefit packages offered by a single sponsor. Nationally, there were approximately 650/800 PD contracts (MA-PD and PDPs combined) in 2008/2010 though the majority of Part D enrollees (72%/73% in 2006/2011) were enrolled in contracts operated by only 10 sponsors. 13, 14 A low-income subsidy that reduces Part D costs to the beneficiary is provided automatically to all Medicaid-eligible beneficiaries plus to additional low-income beneficiaries who provide evidence of income <150% of the Federal Poverty Level and limited assets. 15 The 2 types of Part D coverage, stand-alone PDPs and MA-PDs, have quite different structures. The first is a private Medicare plan just for PD coverage independent of a beneficiary's usual FFS Medicare coverage. The second is an integrated part of a MA plan, a private managed care plan, managed by a private health insurance carrier that provides coverage for all types of health care. For those in MA plans, the transition to MA-PD tended to be subtle; these beneficiaries already had a private managed care plan, whereas FFS beneficiaries were considering a separate, new, private PDP.
Although some have criticized the cost of the Medicare Part D program, recent studies have pointed to the value the program provides in both patient health and in dollar terms. Afendulis et al 16 found that the implementation of the Medicare Part D program was followed by a 4% reduction in hospitalization rates for 8 medication-sensitive conditions in 2006 and 2007. Another study estimates savings in hospital and nursing home costs of about $1200 per newly insured Part D beneficiary, implying overall savings to Medicare of $13.4 billion in 2007, the first full year of the Part D program. 17 In the context of pervasive racial/ethnic disparities for patients of all ages and in particular in patient experiences of Medicare beneficiaries, there is a natural concern about the experiences of racial/ethnic minority beneficiaries with the recently restructured Medicare Part D plans. The new PD coverage options represent a major innovation in the Medicare program, but one with considerable complexity. 18 Some theories suggest that those best positioned to benefit from innovations, at least initially, are those with the most initial advantages, 19 although such innovations may eventually reduce disparities. This suggests that racial/ethnic groups that face additional challenges in health care settings may be at a disadvantage, particularly vulnerable subgroups, such as those with lower SES and language preferences other than English. For instance, the large number of PDPs and MA-PDs available to most beneficiaries creates a potentially challenging enrollment choice for beneficiaries, 18 many of whom have multiple or evolving PD needs. Each PDP and MA-PD has its own formulary and negotiated price structure for prescriptions and premiums, creating potential language and "health literacy" barriers. Hence, any racial/ethnic disparities may vary by beneficiary SES or preferred language. In addition, as the structure and degree of change because of innovations in PD coverage vary dramatically by coverage type, racial/ethnic disparities may also vary by coverage type, and perhaps contract-to-contract.
In particular, our goal in this study was to determine the extent to which Hispanic, Black, and Asian or Pacific Islander (API) Medicare beneficiaries report different experiences with Medicare Part D PD coverage than non-Hispanic White beneficiaries using a large and nationally representative dataset. Findings may inform Centers for Medicare and Medicaid Service's (CMS's) quality improvement and equity efforts and decisions regarding racial/ ethnic-specific public reporting. We posed the following research questions: 1. Are there disparities in Part D experiences for Hispanics, non-Hispanic Blacks, and non-Hispanic APIs relative to non-Hispanic Whites? 2. Are disparities consistent across the 2 Part D coverage types (stand-alone PDP vs. MA-PD)? 3. Do disparities differ by SES and Spanish language preference? 4. How much variation is there in racial/ethnic disparities across Part D contracts?
METHODS

Study Sample
We used the 2008 Medicare Consumer Assessment of Health Care Providers and System (CAHPS s ) survey sample with 407,543 completed surveys (61% response rate). This is a nationally representative stratified random sample of Medicare beneficiaries, with contracts (informally "plans") serving as strata. We focus on the 231,597 Hispanic, non-Hispanic White, non-Hispanic Black, and non-Hispanic API Medicare beneficiaries with PD coverage, age 65 or older, and residing in the continental United States, who had used their PD coverage to obtain prescription medicine in the preceding 6 months. Beneficiaries in Puerto Rico and the Virgin Islands were excluded because of substantial health care differences from the continental US. 20 The following additional exclusions were applied: 29,421 cases (13%) who reported any proxy assistance in responding, 1 case with unknown survey language, 281 Spanish surveys from non-Hispanic respondents, and 398 cases with unknown Medicaid eligibility status, leaving 201,496 beneficiaries (6% Hispanic, 7% non-Hispanic Black, 3% non-Hispanic API, and 84% non-Hispanic White) from 338 MA-PD and 74 stand-alone PDP contracts ( Table 1 ). The study protocol was approved by the RAND Institutional Review Board and the CMS Privacy Board.
Outcome Measures
CMS publicly reports 3 measures of experiences with
Medicare Part D: a global rating of the PD plan/coverage and 2 multi-item composite measures about access to and information about prescription medications. Because prior work suggests racial/ethnic differences in scale use for the 0-10 global rating scale, 21, 22 this paper uses only the 2 composites, which employ a Never/Sometimes/Usually/ Always response scale.
One composite assessed experiences getting needed PDs with 3 questions: in the last 6 months, how often was it easy to use your plan to (1) get the medicines your doctor prescribed?; (2) fill a prescription at your local pharmacy?; and (3) fill a prescription by mail? The 4-item composite regarding experiences getting information from the plan about PD coverage and cost asked: in the last 6 months, how often (1) did your plan give you all the information you needed about which medicines were covered?; (2) did your plan give you all the information you needed about how much you would have to pay for your prescription medicine?; (3) did your plan's customer service give you the information or help you needed about PDs?; and (4) did your plan's customer service staff treat you with courtesy and respect when you tried to get information or help about PDs?
Responses to each question were transformed linearly to a possible range of 0-100 and averaged within composites. Martino et al 23 report Cronbach a of 0.87 for the getting information composite and 0.65-0.67 for the getting needed PD composite for stand-alone PDPs and MA-PDs. Although the internal consistency reliability for the second composite falls just short of the typical 0.70 standard, 
Measures of Race/Ethnicity and Survey Language
Race and ethnicity were determined from 2 items. Hispanic ethnicity was assessed using the standard Office of Management and Budget item (Are you of Hispanic or Latino origin or descent?). Race was measured using an item with 5 response options: White, Black or African American, Asian, Native Hawaiian or other Pacific Islander, and American Indian or Alaska Native. Respondents who endorsed Hispanic or Latino ethnicity were classified as Hispanic. Those responding "no" to Hispanic ethnicity were classified as non-Hispanic White, non-Hispanic Black, non-Hispanic API, or in a multiracial category if Z1 race was reported, or unknown if no race was indicated. In what follows we refer to beneficiaries in the first 4 categories as Hispanic, White, Black, and API, and exclude multiracial beneficiaries and those with unknown race. In some analyses, the Hispanic group is further divided by survey completion language (English or Spanish). In the mainland US, beneficiaries received a bilingual postcard describing the survey and indicating how to request a Spanish survey. This was followed by up to 2 mailings of the English survey, or Spanish language survey if requested. Mail nonrespondents were contacted by phone, with bilingual interviewers and a computerassisted telephone interview administration available.
Independent Variables
We adjusted all results with standard Medicare CAHPS case-mix adjustors 24 and additional characteristics that differ between racial/ethnic groups and may be related to the outcome measures. Five independent variables were selfreported by beneficiaries: sex (Are you male or female?), age (10 response options, of which the categories 65-74, 75-79, 80-84, and 85 or older were used in these analyses), highest completed grade or level of school (eighth grade or less; some high school, but did not graduate; high school graduate or General educational development; some college or 2-year degree; 4-year college graduate; more than 4-year college degree), overall health (Excellent, Very good, Good, Fair, or Poor), and overall mental health (same response options as overall health).
The variables derived from administrative data were coverage type (MA-PD vs. stand-alone PDP); indicators for each MA-PD or stand-alone PDP contract; Medicaid eligibility; and census region of residence. Here we use Medicaid eligibility as a low-SES indicator.
Analysis
Using linear regression we calculated case-mix adjusted means of the 2 PD measures for each of the 4 racial/ ethnic groups (Hispanic, API, Black, and White), and for Hispanics separately by English preferring or Spanish preferring. The means were case-mix adjusted for sex, age, education, overall health, overall mental health, Medicaid eligibility, and census region. We generated case-mix adjusted disparity estimates pooled over coverage type and for the stand-alone PDP and MA-PD beneficiaries separately by stratifying the above model. Next, we checked for differences in disparities by Medicaid eligibility status by adding Medicaid by race/ethnicity interactions to the above model, pooling over coverage type.
We calculated average within-plan disparities and plan-specific disparities for the 2 PD measures using a mixed-effect model. The fixed effects were 3 race/ethnicity indicators (Black, Hispanic, and API) and the case-mix adjustors listed above; the random effects were for contract and 3 additional random slope effects for contract by race/ ethnicity (Black, Hispanic, and API) that allow disparities to vary across contracts. We calculated adjusted, shrunken, within-plan estimates of racial/ethnic disparities, averaged them across the 2 PD experience measures, and classified plans into largest (top decile), smallest (bottom decile), or moderate disparity categories.
All analyses employed person-level poststratification weights 25, 26 that account for sample design and nonresponse by matching weighted sample and enrolled populations in each contract by county combination on sex, age, race/ethnicity, Medicaid eligibility/low-income subsidy enrollment status, Special Needs Plan enrollment, and zip-code level distributions of income, education, and race/ethnicity. Table 1 shows individual characteristics overall and by racial/ethnic group. Non-Hispanic White beneficiaries are least likely and Hispanics the most likely to enroll in MA plans (vs. PDPs). Approximately 45% of racial/ethnic minorities but only 12% of non-Hispanic Whites are Medicaid eligible (21% of all beneficiaries in PDPs and 9% of those in MA-PDs). White beneficiaries are older and in better health than Hispanic, Black, and API beneficiaries, and have educational attainment levels higher than Hispanic and Black beneficiaries but lower than API beneficiaries. Table 2 shows that Hispanics, Blacks, and API report significantly greater difficulty getting needed drugs than White beneficiaries, with adjusted disparities of À 8 points for APIs, À 6 points for Hispanics, and À 4 points for Blacks (P < 0.001 for each vs. non-Hispanic Whites). Similarly, all 3 groups also report significantly greater difficulty than non-Hispanic Whites with getting information about their PD coverage. Disparities are much larger for Spanish-preferring than English-preferring Hispanic beneficiaries on getting needed drugs.
RESULTS
Disparities for getting needed drugs are 1.3 (Black) and 2.7 (API) contract-level SDs, and are 3.6 and 1.4 contract-level SDs for Spanish-preferring and English-preferring Hispanic beneficiaries, respectively. The magnitude of disparities on the getting needed information composite is lower but still striking, ranging from 0.9 to 2.3 contract-level SDs. Thus differences in Part D experiences by race/ethnicity are as large as the overall differences in experience between average plans and top decile plans. We see significant disparities by race/ethnicity in both MA-PDs and stand-alone PDPs for each of the 2 composites, except that the disparity for Spanish-preferring MA-PD Hispanics is not statistically significant for getting needed information. In 8 of 10 cases, the disparity estimates are larger in stand-alone PDPs than in MA-PD.
Disparities by Medicaid eligibility appear in Table 3 . Although disparities relative to Medicaid-ineligible Whites are similar for lower and higher income Blacks, they are approximately twice as large for lower income than higher income Hispanic and API beneficiaries (P < 0.001 for differences in disparities by Medicaid eligibility). For Whites, Medicaid eligibility is associated with similar or better experiences.
Next we turn to results on the degree to which these disparities exist within plans, as opposed to between plans, and the degree to which the within-plan disparities vary by plan. Average within-plan disparities for Hispanic beneficiaries are 87%-90% the size of the overall disparities for this group (results not shown). Thus enrollment of Hispanic seniors in lower quality plans explains about 10% of overall disparities. Average within-plan disparities for Black beneficiaries are 3%-26% larger than the overall disparities; similarly, within-plan disparities for API beneficiaries average 9% larger than overall disparities. Thus Black and API beneficiaries are enrolled in plans with somewhat higher than average quality, partly compensating for larger average within-plan disparities. Table 4 illustrates the characteristics of plans with the smallest and largest disparities (top and bottom decile of disparities) compared with plans with moderate disparities (8 middle deciles). For Hispanics, the plans with the largest disparities have a higher proportion of beneficiaries who are Medicaid eligible, in fair or poor health, and have no high school degree. Larger-disparity plans are more likely to serve beneficiaries primarily in the northeast, whereas plans with the smallest API disparities tend to primarily serve beneficiaries in the west. For all 3 minority groups the smallest disparity plans are especially likely to enroll beneficiaries from the racial/ethnic group for whom the disparity is smallest, a pattern that is strongest for API.
DISCUSSION
Hispanic, Black, and API beneficiaries reported greater difficulties obtaining information regarding coverage and obtaining needed PDs by their Medicare Part D coverage (MA-PD and PDPs) than white beneficiaries with the greatest disparities observed for API beneficiaries and Spanish-preferring Hispanic beneficiaries. Generally, smaller disparities in MA-PD than in PDPs are consistent with the transition to MA-PD being less challenging for those previously enrolled in MA than that to PDPs for those with FFS Medicare. Larger disparities for low-income API and Hispanic beneficiaries (but not for lower-income Blacks) suggest that economic, language, and cultural issues may be important in API and Hispanic PD disparities.
Similarly, we find that plans with the largest disparities for Hispanics tend to have beneficiaries lower in income and education. Although the highest disparity plans for each minority group serve substantial proportions of minority beneficiaries with PD coverage, minority beneficiaries disproportionately enroll in plans with smaller or no disparities.
The magnitude of the observed racial/ethnic disparities in getting information and needed care about medicines is substantial, and generally larger than what has been seen for other aspects of Medicare or for the CAHPS Hospital Survey. 7 Similar to a study of racial/ethnic disparities in clinical quality measures in MA plans 6 but unlike some other previous CAHPS studies of hospitals and Medicare plans, 7, 8 we find that virtually all differences occur within plans.
Possible limitations to this study include the issues of potentially differing expectations and scale use by racial/ethnic group. Restricting our comparisons to CAHPS report composites rather than global ratings is likely to have limited these concerns, given recent experimental evidence of similar use of CAHPS composites by Blacks, Whites, and Hispanics. 27 As we have excluded responses from proxies, our results apply directly only to beneficiaries able to complete the survey independently; disparities may be larger or smaller among those requiring assistance. As with all surveys, nonresponse bias may have influenced the observed findings. Nevertheless, research regarding CAHPS surveys has found little evidence of nonresponse bias after case-mix adjustment. [28] [29] [30] These results suggest that quality improvement efforts are needed to reduce racial/ethnic disparities in beneficiary experience with new Part D PD coverage, especially for lowincome API and Hispanic beneficiaries and those with preferred languages other than English. Cultural, health literacy, and language barriers in navigating the new and complex Medicare's Part D program may partially explain the observed disparities. Substantial variation in disparities across plans suggests that plans may differ in the extent to which they are successful in addressing barriers that racial/ethnic/ linguistic minorities may have in making best use of Part D coverage. Cultural competency training of providers and customer service agents, access to interpreter services, and translation of materials into non-English languages are some of the strategies that can be used to improve the experiences of vulnerable beneficiaries. The fact that disparities disappear in some plans suggests that within-plan disparities in Part D experiences are not inevitable, and there may be best practices that reduce or eliminate disparities in Part D experiences that can be conveyed to other plans. CMS should monitor and alert contracts with large disparities to their need for improvement. "Drill-down" public reporting of contract-level scores by race/ethnicity, as mandated by the Medicare Improvements for Patients and Providers Act of 2008, may also be helpful to beneficiaries and their advocates.
Finally, different disease distributions across racial/ ethnic groups may make it relatively more difficult for minority beneficiaries to find a PD formulary that best matches health needs. Further research is needed to determine the mechanisms causing the disparities we observe in almost all MA-PD and stand-alone PDP contracts on beneficiary reported experiences. Such research can guide policy or contract efforts to better address the needs of Hispanic, Black, and API Medicare beneficiaries regarding prescription medicines.
